Kapil Bhalla

UT MD Anderson Cancer Center

NIH Rank #9308
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.4M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#9,308
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.4M across 3 grants · National rank #9308.

Top grants by award amount

Kapil Bhalla's NIH grant portfolio, ranked by award amount.

  • 5R01CA262636-04R01
    Novel combination therapy for AML expressing mutant RUNX1
    $507.5K
    award amount
  • 5R01CA255721-04R01
    Biology and novel therapy of AML expressing somatic or germline mutant RUNX1
    $472.1K
    award amount
  • 5R01CA233457-05R01
    Targeting dysregulated transcriptome as therapy for post-myeloproliferative neoplasm (MPN) sAML
    $452.1K
    award amount

Affiliation

Institutions that have administered grants for Kapil Bhalla.

Affiliated with UT MD Anderson Cancer Center (TX).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #9308